A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Recruiting · NCT07719361 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study in Patients With Metastatic Castration-Resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 | 2026-09-24 | NCT07719361 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Flare Therapeutics Inc. | 2 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| NEXT Houston | Houston | United States | 11 |
| NEXT Oncology | San Antonio | United States | 70 |
| START Carolinas | Myrtle Beach | United States | 3 |
| START Dallas-Fort Worth | Fort Worth | United States | 1 |
| START Los Angeles | Los Angeles | United States | 14 |
| START Midwest | Grand Rapids | United States | 79 |
| START New Jersey | East Brunswick | United States | 16 |
| Tennessee Oncology | Nashville | United States | 77 |